Your browser doesn't support javascript.
loading
Maternal Near Miss in Patients with Systemic Lupus Erythematosus / Near miss materno em pacientes com lupus eritematoso sistêmico
Silva, Arlley Cleverson Belo da; Sun, Sue Yazaki; Campanharo, Felipe Favorette; Morooka, Letícia Tiemi; Cecatti, José Guilherme; Mattar, Rosiane.
Affiliation
  • Silva, Arlley Cleverson Belo da; Universidade Federal de São Paulo. Escola Paulista de Medicina. São Paulo. BR
  • Sun, Sue Yazaki; Universidade Federal de São Paulo. Escola Paulista de Medicina. São Paulo. BR
  • Campanharo, Felipe Favorette; Universidade Federal de São Paulo. Escola Paulista de Medicina. São Paulo. BR
  • Morooka, Letícia Tiemi; Universidade Federal de São Paulo. Escola Paulista de Medicina. São Paulo. BR
  • Cecatti, José Guilherme; Universidade Estadual de Campinas. Campinas. BR
  • Mattar, Rosiane; Universidade Federal de São Paulo. Escola Paulista de Medicina. São Paulo. BR
Rev. bras. ginecol. obstet ; 45(1): 11-20, 2023. tab, graf
Article in English | LILACS | ID: biblio-1431614
Responsible library: BR26.1
ABSTRACT
Abstract Objective Systemic lupus erythematosus (SLE) may cause irreversible organ damage. Pregnancy with SLE may have severe life-threatening risks. The present study aimed to determine the prevalence of severe maternal morbidity (SMM) in patients with SLE and analyze the parameters that contributed to cases of greater severity. Methods This is a cross-sectional retrospective study from analysis of data retrieved from medical records of pregnant women with SLE treated at a University Hospital in Brazil. The pregnant women were divided in a control group without complications, a group with potentially life-threatening conditions (PLTC), and a group with maternal near miss (MNM). Results The maternal near miss rate was 112.9 per 1,000 live births. The majority of PLTC (83.9%) and MNM (92.9%) cases had preterm deliveries with statistically significant increased risk compared with the control group (p = 0.0042; odds ratio [OR] 12.05; 95% confidence interval [CI] 1.5-96.6 for the MNM group and p = 0.0001; OR 4.84; 95%CI 2.2-10.8 for the PLTC group). Severe maternal morbidity increases the risk of longer hospitalization (p < 0.0001; OR 18.8; 95%CI 7.0-50.6 and p < 0.0001; OR 158.17; 95%CI 17.6-1424,2 for the PLTC and MNM groups, respectively), newborns with low birthweight (p = 0.0006; OR 3.67; 95%CI 1.7-7.9 and p = 0.0009; OR 17.68; 95%CI 2-153.6) for the PLTC and MNM groups, respectively] as well as renal diseases (PLTC [8.9%; 33/56; p = 0.0069] and MNM [78.6%; 11/14; p = 0.0026]). Maternal near miss cases presented increased risk for neonatal death (p = 0.0128; OR 38.4; 95%CI 3.3-440.3]), and stillbirth and miscarriage (p = 0.0011; OR 7.68; 95%CI 2.2-26.3]). Conclusion Systemic lupus erythematosus was significantly associated with severe maternal morbidity, longer hospitalizations, and increased risk of poor obstetric and neonatal outcomes.
RESUMO
Resumo Objetivo Lúpus eritematoso sistêmico (LES) pode causar danos irreversíveis aos órgãos. A gravidez com LES pode ter riscos para condições ameaçadoras à vida. O presente estudo teve como objetivo determinar a prevalência de MMG em pacientes com LES e analisar os parâmetros que contribuíram para os casos de maior gravidade. Métodos Trata-se de um estudo transversal retrospectivo a partir da análise de dados obtidos de prontuários de gestantes com LES atendidas em um Hospital Universitário no Brasil. As gestantes foram divididas em grupo controle sem intercorrências, grupo com condições potencialmente ameaçadoras a vida (CPAV) e grupo com near miss materno (NMM). Resultados A taxa de NMM foi de 112,9 por 1.000 nascidos vivos. A maioria dos casos de CPAV (83,9%) e NMM (92,9%) teve partos prematuros com risco aumentado estatisticamente significativo em comparação com o grupo controle (p = 0,0042; odds ratio [OR] 12,05; intervalo de confiança [IC] 1,5-96,6 para o grupo NMM e p = 0,0001; OR 4,84; IC95% 2,2-10,8 para o grupo CPAV). MMG aumenta o risco de maior tempo de internação (p < 0,0001; OR 18,8; IC95% 7,0-50,6 e p < 0,0001; OR 158,17; IC95% 17,6-1424,2 para os grupos CPAV e NMM, respectivamente), recémnascidos com baixo peso (p = 0,0006; OR 3,67; IC95% 1,7-7,9 e p = 0,0009; OR 17,68; IC95% 2-153,6 para os grupos CPAV e NMM, respectivamente), bem como doenças renais (CPAV 58,9%; 33/56; p = 0,0069 e NMM 78,6%; 11/14; p = 0,0026)]. Os casos de NMM apresentaram risco aumentado para óbito neonatal (p = 0,0128; OR 38,4; IC95% 3,3-440,3), natimorto e aborto espontâneo (p = 0,0011; OR 7,68; IC95% 2,2-26,3). Conclusão Lúpus eritematoso sistêmico foi significativamente associado à morbidade materna grave, internações mais longas e risco aumentado de desfechos obstétricos e neonatais ruins.
Subject(s)


Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.1 Reduce Maternal Mortality / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Target 3.1: Reduce maternal mortality / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Target 3.2: Reduce avoidable death in newborns and children under 5 / Abortion / Immune Disorders / Musculoskeletal Diseases and Rheumatic Disorders / Other Respiratory Diseases / Noncommunicable Diseases Database: LILACS Main subject: Pregnancy, High-Risk / Brief, Resolved, Unexplained Event / Maternal Death / Lupus Erythematosus, Systemic Type of study: Observational study / Prevalence study / Risk factors Limits: Female / Humans / Pregnancy Language: English Journal: Rev. bras. ginecol. obstet Journal subject: Gynecology / Obstetrics Year: 2023 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual de Campinas/BR / Universidade Federal de São Paulo/BR

Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.1 Reduce Maternal Mortality / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Target 3.1: Reduce maternal mortality / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Target 3.2: Reduce avoidable death in newborns and children under 5 / Abortion / Immune Disorders / Musculoskeletal Diseases and Rheumatic Disorders / Other Respiratory Diseases / Noncommunicable Diseases Database: LILACS Main subject: Pregnancy, High-Risk / Brief, Resolved, Unexplained Event / Maternal Death / Lupus Erythematosus, Systemic Type of study: Observational study / Prevalence study / Risk factors Limits: Female / Humans / Pregnancy Language: English Journal: Rev. bras. ginecol. obstet Journal subject: Gynecology / Obstetrics Year: 2023 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual de Campinas/BR / Universidade Federal de São Paulo/BR
...